Sage Journals: Discover world-class research

Open access

Research article

First published 2022

Patents as a Driver of the Unprecedented Biomedical Response to COVID-19

Adam Mossoff, Amesh Adalja

INQUIRY: The Journal of Health Care Organization,Provision,and Financing

Retricted access

Article commentary

First published 2022-3

An Economic Case for Waiving Intellectual Property Rights on Covid Vaccines

Gopal Krishna Roy

India Quarterly: A Journal of International Affairs

Retricted access

Research article

First published 2018-12

The SPC manufacturing waiver: Good for patients,good for jobs,good for Europe

Tomos Shillingford

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Open access

Research article

First published 2022

A Global Intellectual Property Waiver is Still Needed to Address the Inequities of COVID-19 and Future Pandemic Preparedness

Tahir Amin, Aaron S. Kesselheim

INQUIRY: The Journal of Health Care Organization,Provision,and Financing

Open access

Research article

First published 2023-8

COVID-19 and Global Distributive Justice: ‘Health Diplomacy’ of India and South Africa for the TRIPS waiver

Bawa Singh, Vijay Kumar Chattu, Jaspal Kaur [...]

Journal of Asian and African Studies

Open access

Research article

First published 2023-10

Canada and the pharmaceutical industry in the time of COVID-19

Joel Lexchin

International Journal of Social Determinants of Health and Health Services

Retricted access

Research article

First published 2022-2

Analyzing the Morality of Owning and Suspending Patent Rights for COVID-19 Vaccines in the Light of Catholic Social Teaching

Vivencio O. Ballano

The Linacre Quarterly

Free access

Editorial

First published 2016-6

Synergic development of pharmacokinetics and bioanalytical methods as support of pharmaceutical research

M Marzo, R Ciccarelli, P Di Iorio [...]

International Journal of Immunopathology and Pharmacology

Search results